| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |